Urokinase Plasminogen Activator Receptor-positive Solid Tumor
Oncology
0 drugs in development·0 companies·1 clinical trial
Deep-dive into Urokinase Plasminogen Activator Receptor-positive Solid Tumor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis